Edward Allera and Linda Pissott Reig, Shareholders in the firm's FDA & Biotechnology section, were quoted in Corporate Counsel's article "FDA Opioid Painkiller Removal Request a First for the Agency" about the FDA's recent request to remove Opana ER from the market.